CTRI/2018/06/014402Not yet recruitingPhase 1
EVALUATE THE EFFICACY OF KALYANKALP (TABLET) IN THE MANAGEMENT OF STHOULYA. - EEKKS
MS MB LIFE SCIENCES0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.PRESENCE OF OBESITY i.e., WEIGHT IS MORE THAN 20% EXCESS OF THE DESIRABLE WEIGHT ACCORDING TO HEIGHT, SEX AND AGE
- •2. WHR i.e., WAIST HIP CIRCUMFERENCE RATIO >0.95 IN MALES AND >0.8 IN FEMALES
Exclusion Criteria
- •PREGNANCY, LACTATION
- •CHRONIC LIVER, KIDNEY DISORDERS
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of efficacy and efficiency of a removable esthetic appliance for solving teeth crowding in the childhood: a randomized clinical trialRBR-9kvw9tCAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Completed
Phase 1
The efficacy determination and evaluation on the acute cutaneous tolerance of abalone extract (Part: Evaluation on the acute cutaneous tolerance of Abalone extractHealthy Thai male and female volunteers (20-60 years old)Skin irritation, Patch testTCTR20220210002Phuket Abalone Farm Co., Ltd33
Active, not recruiting
Not Applicable
Evaluation of the effectiveness and the tollerability of paracetamol 1000 mgs + caffeine 130 mgs in the treatment of the migraine. I study randomizzato, double blind, double dummy, vs. sumatriptan 50 mgs and placebo - NDPatients will be enlisted you cut from migraine with and without aura (codes 1.1 and 1.2.1, according to the criterions defined by the International Classification ICH2 of the 2004)MedDRA version: 9.1Level: HLGTClassification code 10019231EUCTR2010-019083-36-IT.O. Tossicologia
Not yet recruiting
Phase 2
Triple Antibiotic Gel as an addition to cleaning of teeth for the Treatment of gum diseaseCTRI/2022/09/045747Dr L Krishna Prasad
Active, not recruiting
Not Applicable
An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chronic nociceptive, mixed or neuropathic low back pain taking either WHO Step I or Step II analgesics or no regular analgesics - NDlow back painMedDRA version: 12.0Level: LLTClassification code 10024891Term: Low back painEUCTR2009-010427-12-ITGrünenthal GmbH180